TABLE 3.
Total N = 1,600 | 2012 N = 199 | 2013 N = 232 | 2014 N = 204 | 2015 N = 224 | 2016 N = 221 | 2017 N = 185 | 2018 N = 182 | 2019 N = 153 | |
---|---|---|---|---|---|---|---|---|---|
Site of infection described | 1,200 (75%) | 158 (79.4%) | 191 (82.3%) | 180 (88.2%) | 164 (73.2%) | 185 (83.7%) | 116 (62.7%) | 113 (62.1%) | 93 (60.8%) |
Severity described | 973 (60.8%) | 85 (42.7%) | 151 (65.1%) | 146 (71.6%) | 117 (52.2%) | 179 (81%) | 102 (55.1%) | 115 (63.2%) | 78 (51.0%) |
Microbiological samples taken | 943 (58.9%) | 97 (48.7%) | 124 (53.5%) | 122 (59.8%) | 142 (63.4%) | 121 (54.8%) | 120 (64.9%) | 110 (60.4%) | 107 (69.9%) |
Combination treatment | 311 (19.4%) | 43 (21.6%) | 43 (18.5%) | 43 (21.1%) | 43 (19.2%) | 38 (17.2%) | 41 (22.2%) | 28 (15.4%) | 32 (20.1%) |
Duration ≤7 days | 1,280 (80%) | 144 (72.4%) | 180 (77.6%) | 166 (81.4%) | 189 (84.4%) | 181 (81.9%) | 150 (81.1%) | 141 (77.5%) | 129 (84.3%) |
N(%), number of patients (percentage).